Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Certified proof of sustainability in the areas of environment, labor, ethics and procurement is becoming increasingly important for companies and their suppliers. Almost half of the world’s leading pharmaceutical companies use the EcoVadis assessment...
read more
AdvantaPure is now a GORE STA-PURE Pump Tubing systems integrator for biopharm and pharmaceutical applications.
read more
ADMA Biologics Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that it has received U.S. FDA approval for its ADMA BioCenters plasma ...
read more
Wednesday, September 08, 2021
ADMA Biologics, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that the FDA has granted approval for the Company’s in-house aseptic fill-finish ...
read more
Tuesday, January 07, 2020
ADMA Biologics announced a five-year manufacturing and supply agreement to produce and sell plasma-derived intermediate fractions from ADMA’s FDA approved Immune Globulin manufacturing process.
read more
Adial and Tedor Pharma announced they entered into a collaboration agreement to provide cGMP contract manufacturing services for AD04.
read more
Monday, September 25, 2017
ADC Biotechnology announces it has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK.
read more
Monday, February 12, 2018
ADC Biotechnology (ADC Bio) is developing a ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing.
read more
Wednesday, December 01, 2021
Adare, a technology-driven contract development and manufacturing organization (CDMO), announced today the acquisition of Frontida BioPharm, a vertically integrated CDMO focused on oral formulations.
read more
Adare Pharma Solutions announced it has strengthened its executive leadership team with two key hires. Robert Muschert has joined Adare as Chief Commercial Officer, and Dr. Vipan Dhall has joined as Chief Scientific Officer.
read more
Wednesday, January 27, 2021
Adare Pharma Solutions has announced the opening of a new small-scale development laboratory in Vandalia, Ohio.
read more
Adare Pharmaceuticals has acquired pharmaceutical technology company, Orbis Biosciences.
read more
AGC Biologics is partnering with AdaptVac to develop and produce a COVID-19 vaccine.
read more
Friday, September 13, 2019
Acura Pharmaceuticals has engaged Catalent to initiate manufacturing scale-up of LTX-03 Tablets to ultimately be used in clinical testing.
read more
Wednesday, October 09, 2019
Aclaris announced the company, together with Allergan, has filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Taro.
read more